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Abstract
Background: Burkholderia pseudomallei, the etiologic agent of melioidosis, is endemic to tropic regions, mainly in
Southeast Asia and northern Australia. Melioidosis occurs only sporadically in travellers returning from
disease-endemic areas. Severe clinical disease is seen mostly in patients with alteration of immune status. In
particular, pericardial effusion occurs in 1-3% of patients with melioidosis, confined to endemic regions. To our best
knowledge, this is the first reported case of melioidosis in a traveller complicated by a hemodynamically significant
pericardial effusion without predisposing disease.
Case presentation: A 44-year-old Caucasian man developed pneumonia, with bilateral pleural effusions and
complicated by a hemodynamically significant pericardial effusion, soon after his return from Thailand to
Switzerland. Cultures from different specimens including blood cultures turned out negative. Diagnosis was only
accomplished by isolation of Burkholderia pseudomallei from the pericardial aspirate, thus finally enabling the
adequate antibiotic treatment.
Conclusions: Melioidosis is a great mimicker and physicians in non-endemic countries should be aware of its
varied manifestations. In particular, melioidosis should be considered in differential diagnosis of pericardial effusion
in travellers , even without risk factors predisposing to severe disease.
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Background
Melioidosis is a great mimicker and on clinical grounds it
is often impossible to differentiate it from other acute and
chronic bacterial infections. Definite diagnosis relies on
isolation and identification of its causative agent, Burkhol-
deria pseudomallei [1,2]. In different endemic regions,
pericardial effusion occurs in 1-3% of patients with meli-
oidosis [1]. We present a case of severe melioidosis with a
hemodynamically significant pericardial effusion in a trav-
eller returning to a non-endemic region.
Case presentation
A 44-year-old Caucasian man from Switzerland devel-
oped fever and productive cough, two weeks after return-
ing from north-eastern Thailand, were he had stayed
from December 2008 until February 2009. The general
practitioner treated the patient for community-acquired
pneumonia with amoxicillin-clavulanate for seven days.
After initial improvement, the patient became febrile and
dyspneic again.
On admission the patient was febrile (38.3°C), had a
tachycardia of 130 beats/minute, a blood pressure of
120/78 mmHg, and a respiratory rate of 40/min.
Although the patient showed jugular venous disten-
tion, neither Kussmaul’s sign nor hepatomegaly or per-
ipheral oedema were observed.
Laboratory tests revealed anaemia (hemoglobin 125 g/l,
hematocrit 0.37), leucocytosis, (16.6 G/l; 80% neutrophils,
12% lymphocytes), elevated C-reactive protein (141 mg/l)
and elevated B-type natriuretic peptide (208 ng/l). Labora-
tory screening for autoimmune diseases and vasculitis was
negative. Electrocardiogram showed sinus tachycardia and
low QRS voltage.
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A chest radiograph showed bilateral pleural effusions
and an enlarged cardiac silhouette. Computed tomog-
raphy (CT) of the chest confirmed bilateral pleural effu-
sions, with atelectasis of the inferior lobes, mediastinal
lymphadenopathy and a prominent pericardial effusion.
Abdominal CT showed a small intra-abdominal fluid
collection.
Echocardiography confirmed a hemodynamic relevant
pericardial effusion with diastolic compression of the
right ventricle and a leftventricular ejection fraction of
55%. After pericardiocentesis and aspiration of 700 ml of
a clear yellowish fluid the right ventricular function nor-
malized, the leftventricular ejection fraction raised to
65%, and the QRS voltage normalized.
Pleural effusion (1.07 G/l leucocytes, 33% monocytes/
macrophages, 54% lymphocytes, 13% polymorpho-
nuclear neutrophil leucocytes; LDH 144 U/l with normal
range of LDH in serum <265 U/l ,and with a pleural
fluid/serum-quotient of 0.4 for LDH and 0.4 for total
protein, respectively) was negative on Gram- and Ziehl-
Neelsen stains and negative by Polymerase Chain Reac-
tion Assay for Mycobacterium tuberculosis complex.
Cultures remained negative for bacteria, including myco-
bacteria and fungi. Cultures of two sputum samples
from the same day yielded normal upper respiratory
tract flora. Four sets of blood cultures taken on four
consecutive days remained sterile and urine was negative
for Legionella antigen.
Pericardial effusion (1.4 G/l leucocytes, 58% monocytes/
macrophages, 23% lymphocytes, 19% polymorphonuclear
neutrophil leucocytes; pericardial fluid/serum-quotient of
0.6 for total protein content and of 2.3 for LDH activity,
respectively) was negative on Ziehl-Neelsen stain and
mycobacterial cultures remained negative. Two blood
culture sets were inoculated with pericardial aspirate
(10 ml volume per bottle), and a Gram-negative bacillus
was isolated from both aerobic bottles after 35 hours
of incubation in a BACTEC™ 9240 Blood Culture
Analyzer (Becton Dickinson AG, Allschwil, Switzerland).
Although identified as Burkholderia cepacia in a UNMIC/
ID-62 panel of the Phoenix Automated Microbiology
System (Becton Dickinson AG, Allschwil, Switzerland),
diagnosis was regarded as tentative, since identification
of B. cepacia by common automated identification
instruments should be confirmed by molecular tests
[3,4]. Furthermore, pericardial effusion is an unusual
location for occurrence of B. cepacia [3] and the isolate
was unexpectedly sensitive to amoxicillin-clavulanate
(MIC <= 4/2 mg/L). Analysis of the isolate by API
20NE biochemical test panel V7.0 (bioMérieux, Geneva,
Switzerland) yielded Burkholderia pseudomallei (profile
1156577; 99.9%, ID, 1.0 T). Amplification and sequen-
cing of a 500-bp fragment of the 16S rRNA gene by
Fast MicroSeq 500 16S rDNA Bacterial Identification
Kit and a PRISM 3130 Genetic Analyzer (Applied
Biosystems, Foster City, CA, USA) with sequence ana-
lysis by MicroSeq ID Microbial Identification Software
(Applied Biosystems, Foster City, CA, USA) confirmed
the isolate as B. pseudomallei (DQ108392, 481-bp con-
sensus length). Multilocus sequence typing (MLST) [5]
of the isolate revealed the allelic profile 1/1/4/1/5/4/1,
corresponding to B. pseudomallei sequence type 207,
which has first been isolated from a patient in Thailand
with invasive melioidosis in 2001 [6]. The isolate was
sensitive to amoxicillin-clavulanate (2 μg/mL), ceftazidime
(1.5 μg/mL), doxycycline (3 μg/mL) and trimethoprim-
sulfamethoxazole (0.75/0.0375 μg/mL). Susceptibility
testing was carried out by Etest (AB BIODISK, Sweden)
and interpreted according to guidelines established by
CLSI [7].
The patient received ceftazidime 2 g every 6 hours for 2
weeks followed by maintenance treatment for three
months with doxycycline, trimethoprim-sulfamethoxazole
and leucovorine. The patient fully recovered after four
months and suffered no relapse in the two years follow-up.
Discussion
Our patient developed signs of respiratory illness within
the usual incubation period for melioidosis of 1-21 days,
shortly after leaving northeastern Thailand, an endemic
region for this illness. As Switzerland is not among those
countries, where autochthonous cases of melioidosis
have been reported [1], the patient probably acquired
the infection during his stay in Thailand.
Pneumonia results from haematogenous spread of
B. pseudomallei to the lung following inoculation through
exposure to muddy soils or surface water or alternatively
by inhalation, as the two main modes of infection [1,8].
Although melioidosis occurs in all age groups, severe
clinical disease, such as septicaemic pneumonia, is seen
mostly in patients with alteration of immune status, e.g.
diabetes, chronic renal failure or alcoholism [8]. Our pa-
tient had neither a clinical risk factor for melioidosis nor
any other underlying disease.
Epidemiologic considerations are very important in
the management of pericardial effusion, as in devel-
oped countries acute idiopathic pericarditis and idio-
pathic pericardial effusion are the most common
etiologies, whereas in some underdeveloped geographic
areas tuberculous pericarditis is the leading cause of
pericardial effusion [9]. In a systematic analysis of 106
pericardial fluid samples from France, a non-endemic
country for melioidosis, B. pseudomallei was not
among the detected bacterial agents [10]. Even in en-
demic regions, pericardial effusion caused by B. pseu-
domallei is a rare phenomenon. In the Darwin
prospective melioidosis study from tropical Australia
only four of 540 documented cases had pericarditis,
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three of them with pulmonary infection [11]. In a
10-years retrospective study from Thailand only 12
domestic cases of melioidosis complicated by culture-
confirmed pericarditis were found. One-third of these
patients had underlying diseases and two-third showed
evidence of bacteremia with secondary seeding in the
pericardium [12]. In areas where tuberculosis and
melioidosis are endemic, complicating pericarditis may
only be differentiated by pericardial fluid culture and
findings of pericardial biopsy [12].
As bacteremia could not be detected in our patient,
B. pseudomallei might have gained access into the pericar-
dium through the mediastinal lymph nodes in the course
of pneumonia, known from patients with tuberculosis
[13]. Cultures from different specimens remained negative
for B. pseudomallei. Only culture of pericardial fluid grew
the causative agent, possibly due to the use of blood cul-
ture bottles as primary culture medium. Blood culture
bottles are superior in performance to traditional plated-
medium methods for detection of microorganisms from
sterile body fluids [14]. Detection of B. pseudomallei from
nonsterile specimens such as sputum samples, can be
hampered by the overgrowth and masking of B. pseudo-
mallei by commensal flora, if selective culture media are
not used, that are more common in medical laboratories
situated in countries where the disease is endemic [1].
The initial empiric therapy with orally given
amoxicillin-clavulanate was certainly inadequate as an
intensive phase therapy for melioidosis [1,2]. However,
this may have been responsible for the absence of
growth of B. pseudomallei in other samples, especially in
blood culture. This may also explain why the patient did
not develop a septic shock as recently reported to be
very common in patients with primary pneumonia com-
bined with positive blood culture [15]. The detection of
B. pseudomallei in the pericardial aspirate finally enabled
the adequate, although delayed antibiotic treatment,
22 days after onset of illness.
Conclusions
Melioidosis is a great mimicker and physicians in non-
endemic countries like Switzerland should be aware of
its varied manifestations. In particular, melioidosis
should be considered in the differential diagnosis of peri-
cardial effusion in travellers, even in the absence of risk
factors predisposing to severe disease. To our best
knowledge, this is the first reported case of melioidosis
in a traveller complicated by a hemodynamically signifi-
cant pericardial effusion.
Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review by the Editor-in-Chief of
this Journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DS supervised the microbiological analyses and wrote the manuscript. ThB,
GD, JMR supervised the microbiological analyses and helped to draft the
manuscript. BM and KB contributed to diagnosis and treatment and KB
helped to draft the manuscript and did outpatient follow-up. All authors
read and approved the final manuscript.
Acknowledgments
We are grateful to the patient for permission to publish this case report. The
Center of Laboratory Medicine, St. Gallen, Switzerland and the Bundeswehr
Institute of Microbiology, Munich, Germany funded the microbiological
analyses of the samples as part of the quality improvement program. No
other, especially no commercial funding was received for the study.
Author details
1Center of Laboratory Medicine, Frohbergstrasse 3, CH-9001 St. Gallen,
Switzerland. 2Department of Internal Medicine, Cantonal Hospital,
Rorschacherstrasse 95, CH-9007 St Gallen, Switzerland. 3Bundeswehr Institute
of Microbiology, Neuherbergstr 11, D-80937 Munich, Germany. 4Department
of Internal Medicine, Division of Infectious Diseases, Cantonal Hospital,
Rorschacherstrasse 95, CH-9007 St Gallen, Switzerland.
Received: 4 March 2012 Accepted: 1 October 2012
Published: 4 October 2012
References
1. Cheng AC, Currie BJ: Melioidosis: epidemiology, pathophysiology and
management. Clin Microbiol Rev 2005, 18:383–416.
2. Limmathurotsakul D, Peacock SJ: Melioidosis: a clinical overview. Br Med
Bull 2011, 1–15.
3. Gautam V, Singhal L, Ray P: Burkholderia cepacia complex: Beyond
pseudomonas and acinetobacter. Indian J Med Microbiol 2011,
29:4–12.
4. Weissert C, Dollenmaier G, Rafeiner P, Riehm J, Schultze D: Burkholderia
pseudomallei misidentified by automated system. Emerg Infect Dis 2009,
15:1799–1801.
5. Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, Kinoshita R, Spratt
BG: Multilocus sequence typing and evolutionary relationships among
the causative agents of melioidosis and glanders, Burkholderia
pseudomallei and Burkholderia mallei. J Clin Microbiol 2003,
41(5):2068–2079.
6. Multi locus sequence typing (MLST): London: Imperial College London;
2008. cited 2008 Nov 24. http://bpseudomallei. mlst.net.
7. Clinical and Laboratory Standards Institute: Performance standards for
antimicrobial susceptibility testing; 18th informational supplement, document
M100-S18. PA: Wayne; 2008.
8. Currie BJ: Melioidosis: an important cause of pneumonia in residents of
and travellers returned from endemic regions. Eur Respir J 2003,
22:542–550.
9. Sagristà-Sauleda J, Mercé AS, Soler-Soler J: Diagnosis and management of
pericardial effusion. World J Cardiol 2011, 3(5):135–143.
10. Levy PY, Fournier PE, Charrel R, Metras D, Habib G, Raoult D: Molecular
analysis of pericardial fluid: a 7-year experience. Eur Heart J 2006,
27(16):942–946.
11. Currie BJ, Ward L, Cheng AC: The epidemiology and clinical spectrum of
melioidosis: 540 cases from the 20 year Darwin prospective study.
PLoS Negl Trop Dis 2010, 4:e900.
12. Chetchotisakd PS, Anunnatsiri S, Kiatchoosakun S, Kularbkaew C: Melioidosis
pericarditis mimicking tuberculous pericarditis. Clin Infect Dis 2010,
51:e46–e49.
13. Chung HC, Lee CT, Lai CH, Huang CK, Lin JN, Liang SH, Lin HH: Case
Report: Non-septicemic melioidosis presenting as cardiac tamponade.
AmJTrop Med Hyg 2008, 79:455–457.
Schultze et al. BMC Infectious Diseases 2012, 12:242 Page 3 of 4
http://www.biomedcentral.com/1471-2334/12/242
14. Bourbeau P, Riley J, Heiter BJ, Master R, Young C, Pierson C: Use of the
BacT/Alert Blood Culture System for Culture of Sterile Body Fluids Other
than Blood. J Clin Microbiol 1998, 36(11):3273–3277.
15. Meumann EM, Cheng AC, Ward L, Currie BJ: Clinical features and
epidemiology of melioidosis pneumonia: results from a
21-year study and review of the literature. Clin Infect Dis 2012,
54(3):362–369.
doi:10.1186/1471-2334-12-242
Cite this article as: Schultze et al.: A traveller presenting with severe
melioidosis complicated by a pericardial effusion: a case report. BMC
Infectious Diseases 2012 12:242.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Schultze et al. BMC Infectious Diseases 2012, 12:242 Page 4 of 4
http://www.biomedcentral.com/1471-2334/12/242
